Meredith P. Riebschleger, M.D., M.S.
Clinical Lecturer, Department of Pediatrics and Communicable Diseases, Pediatric Rheumatology
Dr. Riebschleger's research focuses on identifying and improving different mechanisms of health care delivery to stretch the reach of the limited pediatric subspecialty workforce. She is especially interested in the use of patient/parent reported outcomes and telemedicine for children who live far away from academic medical centers like the University of Michigan.
Dr. Riebschleger's clinical interests include the care of children with all forms of rheumatologic diseases.
M.S., Health and Health Services Research, University of Michigan, 2012
M.D., Drexel University College of Medicine, 2005
B.S., Biology, University of Notre Dame, 2001
Riebschleger MP, VanMater HA, Cohn LM, Clark SJ.
Prescription Patterns for Children with Juvenile Idiopathic Arthritis in Michigan Medicaid: A Comparison by Prescriber Type.
Pediatric Rheumatology. 2014;12:38.
Riebschleger MP, McGuinness G, Currin L, Althouse LA, Freed GL.
Noncompletion in pediatric rheumatology fellowships.
J Grad Med Educ. 2014 Mar;6(1):158-61.
Nigrovic PA, Muscal E, Riebschleger MP, Moorthy N, Brunner HI, Eberhard BA, Klein-Gitelman M, Prahalad S, Schneider R.
AMIGO: a novel approach to the mentorship gap in pediatric rheumatology.
J Pediatr. 2014; 164(2):226-227.
Neef HC, Riebschleger MP, Adler J.
Meta-analysis: rapid infliximab infusions are safe.
Alimentary Pharmacology and Therapeutics. 2013;38(4):365-376.
Kimura Y, Weiss JE, Haroldson KL, Lee T, Punaro M, Oliviera S, Rabinovich E, Riebschleger MP, Anton J, Blier PR, Gerloni V, Hazen MM, Kessler E, Onel K, Passo MH, Rennebohm RM, Wallace CA, Woo P, Wulffraat N.
Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis.
Arthritis Care and Research 2013;65(5):745-52.
Riebschleger MP, Haftel HM.
Remediation in the context of the competencies: A survey of pediatrics residency program directors.